-
公开(公告)号:US06210713B1
公开(公告)日:2001-04-03
申请号:US09513074
申请日:2000-02-25
IPC分类号: A61K914
CPC分类号: A61K9/0092 , A47G21/183 , A61J7/0038
摘要: The present invention is an oral active agent delivery system and method for delivering discrete units of an active agent formulation to a patient. An active agent formulation chamber containing the active agent formulation and having a fluid passing active agent formulation retainer is placed at a first end into a fluid and at a second end into a patient's mouth. The active agent is delivered when the patient sips on the second end of the chamber.
摘要翻译: 本发明是一种口服活性剂递送系统和用于将活性剂制剂的离散单元递送给患者的方法。 含有活性剂制剂并具有流体通过的活性剂制剂保持剂的活性剂制剂室在第一端置于流体中,并在第二端置于患者口中。 当患者在房间的第二端上浸泡时,递送活性剂。
-
32.
公开(公告)号:US6153678A
公开(公告)日:2000-11-28
申请号:US167372
申请日:1998-10-06
申请人: Liang-Chang Dong , Crystal Pollock , Patrick S.-L. Wong , Keru O. Shafi , Vincent J. Ferrari , Ted Smith
发明人: Liang-Chang Dong , Crystal Pollock , Patrick S.-L. Wong , Keru O. Shafi , Vincent J. Ferrari , Ted Smith
CPC分类号: C08L71/02 , A61K9/0004 , C08L67/04
摘要: Polymeric compositions are disclosed comprising a poly(caprolactone), a poly(alkylene oxide), a poly(oxyethylenated fatty acid ester), or a poly(oxyethylenated fatty acid), or a poly(oxyethylene-co-oxypropylene).
摘要翻译: 公开了包含聚(己内酯),聚(环氧烷),聚(氧乙烯化脂肪酸酯)或聚(氧乙烯化脂肪酸)或聚(氧乙烯 - 共 - 氧丙烯)的聚合物组合物。
-
33.
公开(公告)号:US6103265A
公开(公告)日:2000-08-15
申请号:US401610
申请日:1999-09-22
申请人: Patrick S.-L. Wong , Vincent J. Ferrari , Jeffrey W. Etter , Miriam A. Martin , Nathan Roth , Christopher M. G. Ohms , Andrew I. Poutiatine , James Horvath
发明人: Patrick S.-L. Wong , Vincent J. Ferrari , Jeffrey W. Etter , Miriam A. Martin , Nathan Roth , Christopher M. G. Ohms , Andrew I. Poutiatine , James Horvath
CPC分类号: A61J7/0038 , A47G21/183 , A61K9/0092
摘要: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.
摘要翻译: 本发明涉及包含改进的流量控制器的口服活性剂递送系统。 含有活性剂制剂并具有流体通过控制器(14)的中空管状构件(10)在一端(16)处放置成流体,并在第二端(18)放置到患者口中。 当患者唾液在腔室的末端时,递送活性剂。 改进的控制器防止活性剂制剂的泄漏。
-
公开(公告)号:US5938654A
公开(公告)日:1999-08-17
申请号:US382947
申请日:1995-02-01
CPC分类号: A61K9/0004 , A61K9/4808
摘要: A dispenser for use in a fluid environment of use which is capable of the delivery of one or a plurality of discrete active agent-containing units in any desired delivery pattern or profile. It also can provide for the initially delayed delivery of an active agent to the environment of use and for high accuracy in the timing of delivery of the active agent.
摘要翻译: 一种在流体使用环境中使用的分配器,其能够以任何期望的递送模式或轮廓递送一个或多个离散的含活性剂的单元。 它还可以提供活性剂在使用环境中的最初延迟递送以及在活性剂递送时间上的高精度。
-
公开(公告)号:US5897878A
公开(公告)日:1999-04-27
申请号:US963967
申请日:1992-10-21
申请人: Liang C. Dong , Michael H. Dealey , Terry L. Burkoth , Patrick S.-L. Wong , Jerry D. Childers , Brian L. Barclay
发明人: Liang C. Dong , Michael H. Dealey , Terry L. Burkoth , Patrick S.-L. Wong , Jerry D. Childers , Brian L. Barclay
CPC分类号: A61K9/0004
摘要: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
摘要翻译: 公开了一种剂型,其包括用于减轻剂型组分对粘膜组织的粘性和/或刺激性的方法。 剂型提供了用于在剂型中形成包含药物的絮凝物,当从剂型递送时,该絮凝剂减轻温血接受者的粘膜组织的粘性和/或刺激性。
-
公开(公告)号:US5869097A
公开(公告)日:1999-02-09
申请号:US970519
申请日:1992-11-02
CPC分类号: A61K9/0004 , A61K9/1635 , A61K9/4808 , A61K9/4816 , A61K9/4891
摘要: An osmotic caplet is disclosed comprising an osmotic caplet exit for delivering a preselected dose of drug to a patient in need of therapy.
摘要翻译: 公开了渗透性囊片,其包括用于将预选剂量的药物递送至需要治疗的患者的渗透性囊片出口。
-
公开(公告)号:US5795591A
公开(公告)日:1998-08-18
申请号:US299867
申请日:1994-09-01
申请人: Eun Soo Lee , Scott A. Bura , Su Il Yum , Patrick S.-L. Wong , Felix Theeuwes
发明人: Eun Soo Lee , Scott A. Bura , Su Il Yum , Patrick S.-L. Wong , Felix Theeuwes
CPC分类号: A61K9/0004
摘要: Osmotically driven drug delivery devices with walls of porous hydrophobic material as the sole diffusion-limiting wall component are disclosed. Despite pores which are considerably larger than the molecular dimensions of osmotically active species in the interior of the device, despite pores which by their hydrophobic character do not permit the passage of liquid water, and despite the absence of a cellulosic semi-permeable membrane, the devices absorb water by osmosis without loss of the osmotically active species, and function in a manner analogous to osmotic pumps of the prior art. By permitting the use of hydrophobic substances as the wall material, the invention permits the device to be constructed entirely from biodegradable materials.
摘要翻译: 公开了具有作为唯一扩散限制壁部件的多孔疏水材料壁的渗透驱动药物输送装置。 尽管孔远远大于装置内部的渗透活性物质的分子尺寸,尽管孔具有疏水性,但不允许液态水通过,尽管不存在纤维素半透膜, 装置通过渗透吸收水分而不损失渗透活性物质,并且以类似于现有技术的渗透泵的方式起作用。 通过允许使用疏水物质作为壁材料,本发明允许该装置完全由可生物降解的材料构成。
-
公开(公告)号:US5785994A
公开(公告)日:1998-07-28
申请号:US862665
申请日:1992-04-01
IPC分类号: A61K9/00 , A61K9/22 , A61K31/155 , A61K31/275 , A61K31/435 , A61K31/55 , A61K9/24
CPC分类号: A61K9/0004
摘要: A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The dosage form in an embodiment comprises a drug on the exterior of the dosage form, which drug is available for immediate delivery.
摘要翻译: 公开了一种剂型,其包含剂型内的装置,用于在剂型从剂型内部递送药物之前提供基本上无药物的间隔。 在一个实施方案中的剂型包含在剂型外部的药物,该药物可用于立即递送。
-
公开(公告)号:US5707663A
公开(公告)日:1998-01-13
申请号:US442425
申请日:1995-05-16
IPC分类号: A61K9/00 , A61K9/16 , A61K9/20 , A61K9/22 , A61K9/26 , A61K9/50 , A61K9/52 , A61K31/16 , A61K31/19 , A61K31/22
CPC分类号: A61K31/22 , A61K31/16 , A61K31/19 , A61K9/0004 , A61K9/1641 , A61K9/2031 , A61K9/2054 , A61K9/5047
摘要: This invention pertains to a dosage form for the management of epilepsies wherein the dosage form comprises administering valproic acid or a valproic acid derivative at a continuous rate over an extended time.
-
公开(公告)号:US5633011A
公开(公告)日:1997-05-27
申请号:US286125
申请日:1994-08-04
CPC分类号: A61K31/57 , A61K9/0004 , A61K9/2004 , A61K9/2086 , A61K9/4808
摘要: A hormone replacement composition, a hormone replacement dosage form, and a method of hormone replacement are disclosed and indicated for the management of hormone replacement therapy.
摘要翻译: 公开了激素替代物组合物,激素替代剂型和激素替代方法,并用于治疗激素替代疗法。
-
-
-
-
-
-
-
-
-